Potential role of free-radical processes in biomolecules damage during COVID-19 and ways of their regulation

References

• Sanders JM, Monogue ML, Jodlowski TZ, et al. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;323(18):1824–1836.
   PubMed Web of Science ®Google Scholar
• Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 5th ed. New York: Oxford Univ. Press; 2015.
   Google Scholar
• De Clercq E. Antiviral drugs in current clinical use. J Clin Virol. 2004;30(2):115–133.
   PubMed Web of Science ®Google Scholar
• De Clercq E. Antivirals: past, present and future. Biochem Pharmacol. 2013;85(6):727–744.
   PubMed Web of Science ®Google Scholar
• Morfin F, Thouvenot D. Herpes simplex virus resistance to antiviral drugs. J Clin Virol. 2003;26(1):29–37.
   PubMed Web of Science ®Google Scholar
• van der Vries E, Schutten M, Fraaij P, et al. Influenza virus resistance to antiviral therapy. Adv Pharmacol. 2013;67:217–246.,
   PubMedGoogle Scholar
• Richman DD. Antiviral drug resistance. Antiviral Res. 2006;71(2-3):117–121.
   PubMed Web of Science ®Google Scholar
• Weber IT, Harrison RW. Tackling the problem of HIV drug resistance. Postepy Biochem. 2016;62(3):273–279.
   PubMedGoogle Scholar
• Griffiths PD. A perspective on antiviral resistance. J Clin Virol. 2009;46(1):3–8.
   PubMed Web of Science ®Google Scholar
• Todt D, Walter S, Brown RJ, et al. Mutagenic effects of ribavirin on hepatitis E virus-viral extinction versus selection of fitness-enhancing mutations. Viruses. 2016;8(10):283.,
   Web of Science ®Google Scholar
• Vivet-Boudou V, Isel C, Safadi YEI, et al. Evaluation of anti-HIV-1 mutagenic nucleoside analogues. J Biol Chem. 2015;290(1):371–383.,
   PubMed Web of Science ®Google Scholar
• Wutzler P, Thust R. Genetic risks of antiviral nucleoside analogues – a survey. Antiviral Res. 2001;49(2):55–74.
   PubMed Web of Science ®Google Scholar
• Antonelli G, Turriziani O. Antiviral therapy: old and current issues. Int J Antimicrob Agents. 2012;40(2):95–102.
   PubMed Web of Science ®Google Scholar
• Wu J. Tackle the free radicals damage in COVID-19. Nitric Oxide. 2020;102:39–41.
   PubMed Web of Science ®Google Scholar
• Buffinton GD, Christen S, Peterhans E, et al. Oxidative stress in lungs of mice infected with influenza A virus. Free Radic Res Commun. 1992;16(2):99–110.,
   PubMed Web of Science ®Google Scholar
• Hennet T, Peterhans E, Stocker R. Alterations in antioxidant defences in lung and liver of mice infected with influenza A virus. J. Gen. Virol. 1992;73(1):39–46.
   PubMedGoogle Scholar
• Akaike T. Role of free radicals in viral pathogenesis and mutation. Rev Med Virol. 2001;11(2):87–101.
   PubMed Web of Science ®Google Scholar
• Camini FC, da Silva Caetano CC, Almeida LT, et al. Implications of oxidative stress on viral pathogenesis. Arch Virol. 2017;162(4):907–917.,
   PubMed Web of Science ®Google Scholar
• Molteni CG, Principi N, Esposito S. Reactive oxygen and nitrogen species during viral infections. Free Radic Res. 2014;48(10):1163–1169.
   PubMed Web of Science ®Google Scholar
• Mendonca P, Soliman KFA. Flavonoids activation of the transcription factor Nrf2 as a hypothesis approach for the prevention and modulation of SARS-CoV-2 infection severity. Antioxidants. 2020;9(8):659.
   Web of Science ®Google Scholar
• Park SE. Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19) ). Clin Exp Pediatr. 2020;63(4):119–124.
   PubMedGoogle Scholar
• Mironova GD, Belosludtseva NV, Ananyan MA. Prospects for the use of regulators of oxidative stress in the comprehensive treatment of the novel Coronavirus Disease 2019 (COVID-19) and its complications. Eur Rev Med Pharmacol Sci. 2020; 24(16):8585–8591.
   PubMed Web of Science ®Google Scholar
• Ye Q, Wang B, Mao J. The pathogenesis and treatment of the `Cytokine Storm' in COVID-19 . J Infect. 2020;80(6):607–613.
   PubMed Web of Science ®Google Scholar
• Khomich OA, Kochetkov SN, Bartosch B, et al. Redox biology of respiratory viral infections. Viruses. 2018;10(8):392.,
   Web of Science ®Google Scholar
• Cecchini R, Cecchini AL. SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression. Med Hypotheses. 2020;143:110102
   PubMed Web of Science ®Google Scholar
• Rello J, Storti E, Belliato M, et al. Clinical phenotypes of SARS-CoV-2: Implications for clinicians and researchers. Eur. Respir. J. 2020;21:2001028.
   Google Scholar
• Xie J, Covassin N, Fan Z, et al. Association between hypoxemia and mortality in patients with COVID-19. Mayo Clin. Proc. 2020;95(6):1138–1147.
   PubMed Web of Science ®Google Scholar
• Xie J, Tong Z, Guan X, et al. Critical care crisis and some recommendations during the COVID-19 epidemic in China. Intensive Care Med. 2020;46(5):837–840.,
   PubMed Web of Science ®Google Scholar
• Leyfman Y, Erick TK, Reddy SS, et al. Potential Immunotherapeutic Targets For Hypoxia Due to COVI-FLU. Shock. 2020;54(4):438–450.
   PubMed Web of Science ®Google Scholar
• Beltrán-García J, Osca-Verdegal R, Pallardó FV, et al. Oxidative stress and inflammation in COVID-19-associated sepsis: the potential role of anti-oxidant therapy in avoiding disease progression. Antioxidants. 2020;9(10):936.
   Web of Science ®Google Scholar
• Koch A, Kähler W, Klapa S, et al. The conundrum of using hyperoxia in COVID-19 treatment strategies: may intermittent therapeutic hyperoxia play a helpful role in the expression of the surface receptors ACE2 and Furin in lung tissue via triggering of HIF-1α? Intensive Care Med Exp. 2020;8:53.
   PubMed Web of Science ®Google Scholar
• Marchetti M. COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure. Ann Hematol. 2020;99(8):1701–1707.
   PubMed Web of Science ®Google Scholar
• Wagener FADTG, Pickkers P, Peterson SJ, et al. Targeting the Heme-Heme Oxygenase System to Prevent Severe Complications Following COVID-19 Infections. Antioxidants. 2020;9(6):540.,
   Web of Science ®Google Scholar
• Henry BM, de Oliveira M, Benoit S, et al. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020;58(7):1021–1028.
   PubMed Web of Science ®Google Scholar
• Gómez-Pastora J, Weigand M, Kim J, et al. Hyperferritinemia in critically ill COVID-19 patients - Is ferritin the product of inflammation or a pathogenic mediator? Clin Chim Acta. 2020;509:249–251.,
   PubMed Web of Science ®Google Scholar
• Perricone C, Bartoloni E, Bursi R, et al. COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy. Immunol Res. 2020;68(4):213–224.
   PubMed Web of Science ®Google Scholar
• Laforge M, Elbim C, Frère C, et al. Tissue damage from neutrophil-induced oxidative stress in COVID-19. Nat Rev Immunol. 2020;20(9):515–516.,
   PubMed Web of Science ®Google Scholar
• Arai H. Oxidative modification of lipoproteins. In: Kato, Y. editor. Lipid hydroperoxide-derived modification of biomolecules. Subcellular Biochemistry. Dordrecht: Springer. 2014;77:103–114.
   Google Scholar
• Fourquet S, Guerois R, Biard D, et al. Activation of NRF2 by nitrosative agents and H2O2 involves KEAP1 disulfide formation. J Biol Chem. 2010;285(11):8463–8471.,
   PubMed Web of Science ®Google Scholar
• Ma Q. Role of Nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol. 2013;53:401–426.
   PubMed Web of Science ®Google Scholar
• Kagan VE. Lipid peroxidation in biomembranes. 1st ed. Boca Raton, Florida: CRC press; 1988.
   Google Scholar
• Arnhold J. Cell and tissue destruction: mechanisms, protection, disorders. New York (NY): Academic Press; 2020. p. 342.
   Google Scholar
• Gaschler MM, Stockwell BR. Lipid peroxidation in cell death. Biochem Biophys Res Commun. 2017;482(3):419–425.
   PubMed Web of Science ®Google Scholar
• Yin H, Xu L, Porter NA. Free radical lipid peroxidation: mechanisms and analysis. Chem Rev. 2011;111(10):5944–5972.
   PubMed Web of Science ®Google Scholar
• Negre-Salvayre A, Auge N, Ayala V, et al. Pathological aspects of lipid peroxidation. Free Radic Res. 2010;44(10):1125–1171.,
   PubMed Web of Science ®Google Scholar
• Shadyro O, Lisovskaya A. ROS-induced lipid transformations without oxygen participation. Chem Phys Lipids. 2019;221:176–183.
   PubMed Web of Science ®Google Scholar
• Shadyro OI. Radiation-induced free radical fragmentation of cell membrane components and the respective model compounds. in: F. Minisci (Eds.), Free radicals in biology and environment., Dordrecht: Kluwer Academic Publishers, 1997. pp. 317–329.
   Google Scholar
• Shadyro O, Samovich S, Edimecheva I. Free-radical and biochemical reactions involving polar part of glycerophospholipids, Free Radic. Free Radic Biol Med. 2019;144:6–15.
   PubMed Web of Science ®Google Scholar
• Edimecheva IP, Kisel RM, Shadyro OI, et al. Homolytic cleavage of the O-glycoside bond in carbohydrates: a steady-state radiolysis study. J Radiat Res. 2005;46(3):319–324.,
   PubMed Web of Science ®Google Scholar
• Sladkova АА, Sosnovskaya АА, Edimecheva IP, et al. Radiation-induced destruction of hydroxyl-containing amino acids and dipeptides. Radiat Phys Сhem. 2012;81(12):1896–1903.,
   Web of Science ®Google Scholar
• Petryaev EP, Moshchinskaya SV, Timoshchuk VA, et al. Effect of structure of the carbohydrate fragment on homolytic cleavage on N-glycosidic and phosphate ester bonds in nucleosides and nucleotides. J Org Chem USSR. 1988;24:982–985.
   Google Scholar
• Teuwen L-A, Geldhof V, Pasut A, et al. COVID-19: the vasculature unleashed. Nat Rev Immunol. 2020;20(7):389–391.,
   PubMed Web of Science ®Google Scholar
• Fernández-Quintela A, Milton-Laskibar I, Trepiana J, et al. Key aspects in nutritional management of COVID-19 patients. JCM. 2020;9(8):2589.,
   Google Scholar
• Amaegberi NV, Semenkova GN, Kvacheva ZB, et al. 2-Hexadecenal inhibits growth of C6 glioma cells. Cell Biochem Funct. 2019;37(4):281–289.,
   PubMed Web of Science ®Google Scholar
• Abu-Farha M, Thanaraj TA, Qaddoumi MG, et al. The role of lipid metabolism in COVID-19 virus infection and as a drug target. IJMS. 2020;21(10):3544.,
   Google Scholar
• Shen B, Yi X, Sun Y, et al. Proteomic and metabolomic characterization of COVID-19 patient sera. Cell. 2020;182(1):59–72.e15.,
   PubMed Web of Science ®Google Scholar
• Paliwal VK, Garg RK, Gupta A, et al. Neuromuscular presentations in patients with COVID-19. Neurol Sci. 2020;41(11):3039–3056.,
   PubMed Web of Science ®Google Scholar
• Shadyro O, Yurkova I, Kisel M, et al. Formation of phosphatidic acid, ceramide, and diglyceride on radiolysis of lipids: identification by MALDI-TOF mass spectrometry, Free Radic. Free Radic Biol Med. 2004;36(12):1612–1624.,
   PubMed Web of Science ®Google Scholar
• Yurkova I, Kisel M, Arnhold J, et al. Free-radical fragmentation of galactocerebrosides: a MALDI-TOF mass spectrometry study. Chem Phys Lipids. 2005;134(1):41–49.,
   PubMed Web of Science ®Google Scholar
• Edwards MJ, Becker KA, Gripp B, et al. Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2. J. Biol. Chem. 2020;295(45):15174–15182.
   Web of Science ®Google Scholar
• Oskeritzian CA, Hait NC, Wedman P, et al. The sphingosine-1-phosphate/sphingosine-1-phosphate receptor 2 axis regulates early airway T-cell infiltration in murine mast cell-dependent acute allergic responses. J Allergy Clin Immunol. 2015;135(4):1008–1018.e1.
   PubMed Web of Science ®Google Scholar
• Abdalla M, Ismail NEM, Mohamed AH, et al. Plasma levels of phospholipids in patients with COVID-19. A Promising simple biochemical parameter to evaluate the disease severity. 2020.
   Google Scholar
• Seeds MC, Grier BL, Suckling BN, et al. Secretory phospholipase A2-mediated depletion of phosphatidylglycerol in early acute respiratory distress syndrome. Am. J. Med. Sci. 2012;343(6):446–451.
   PubMed Web of Science ®Google Scholar
• Kuronuma K, Mitsuzawa H, Takeda K, et al. Anionic pulmonary surfactant phospholipids inhibit inflammatory responses from alveolar macrophages and U937 cells by binding the lipopolysaccharide-interacting proteins CD14 and MD-2. J Biol Chem. 2009;284(38):25488–25500.
   PubMed Web of Science ®Google Scholar
• Numata M, Chu HW, Dakhama A, et al. Pulmonary surfactant phosphatidylglycerol inhibits respiratory syncytial virus-induced inflammation and infection. Proc Natl Acad Sci USA. 2010;107(1):320–325.
   PubMed Web of Science ®Google Scholar
• Bollag WB, Gonzales JN. Phosphatidylglycerol and surfactant: a potential treatment for COVID-19? Med Hypotheses. 2020;144:110277
   PubMed Web of Science ®Google Scholar
• Kitsiouli E, Nakos G, Lekka ME. Phospholipase A2 subclasses in acute respiratory distress syndrome. Biochim Biophys Acta. 2009;1792(10):941–953.
   PubMed Web of Science ®Google Scholar
• Nasi A, McArdle S, Gaudernack G, et al. Reactive oxygen species as an initiator of toxic innate immune responses in retort to SARS-CoV-2 in an ageing population, consider N-acetylcysteine as early therapeutic intervention. Toxicol. Rep. 2020;7:768–771.,
   PubMed Web of Science ®Google Scholar
• Ali OH, Bomze D, Risch L, et al. Severe COVID-19 is associated with elevated serum IgA and antiphospholipid IgA-antibodies. Clin. Infect. Dis. 2020; ciaa1496.
   PubMed Web of Science ®Google Scholar
• Jizzini M, Shah M, Zhou K. SARS-CoV-2 and anti-cardiolipin antibodies. Clin Med Insights Case Rep. 2020;13:1179547620980381
   Web of Science ®Google Scholar
• Samovich S, Edimecheva I, Shadyro O, et al. Free-radical processes resulting in formation of new lipid molecules. Free Rad Biol Med. 2019;139.
   Web of Science ®Google Scholar
• Yao Y, Lawrence DA. Susceptibility to COVID‐19 in populations with health disparities: Posited involvement of mitochondrial disorder, socioeconomic stress, and pollutants. J Biochem Mol Toxicol. 2020;35:e22626.
   PubMed Web of Science ®Google Scholar
• Ott M, Zhivotovsky B, Orrenius S. Role of cardiolipin in cytochrome c release from mitochondria. Cell Death Differ. 2007;14(7):1243–1247.
   PubMed Web of Science ®Google Scholar
• Shenoy S. Coronavirus (Covid-19) sepsis: revisiting mitochondrial dysfunction in pathogenesis, aging, inflammation, and mortality. Inflamm Res. 2020;69(11):1077–1085.
   PubMed Web of Science ®Google Scholar
• Bizunok NA. The antioxidant activity structure determinants of the phenol, diphenol and polyphenols derivatives in regard to ROS, generated by macrophages in various microenvirons, Voennaya meditsina. 1 2013. 84–94 (Engl. Transl.). https://elibrary.ru/item.asp?id=20936579.
   Google Scholar
• Samadi M, Shirvani H, Rahmati-Ahmadabad S. A study of possible role of exercise and some antioxidant supplements against coronavirus disease 2019 (COVID-19): a cytokines related perspective. Apunts Sports Med. 2020;55(207):115–117.
   Web of Science ®Google Scholar
• De Flora S, Balansky R, Maestra SL. Rationale for the use of N‐acetylcysteine in both prevention and adjuvant therapy of COVID‐19. Faseb J. 2020;34(10):13185–13193.
   PubMed Web of Science ®Google Scholar
• Palacios Chavarria A, Valdez Vázquez RR, Domínguez Cherit JG, et al. Open clinical trial of the use of antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia and septic shock due to covid-19, 2020. https://www.researchsquare.com/article/rs-122123/latest.pdf.
   Google Scholar
• Ellen ter BM, Dinesh Kumar N, Bouma EM, et al. Resveratrol and pterostilbene potently inhibit SARS-CoV-2 infection in vitro. bioRxiv. 2020.
   Google Scholar
• Jovic TH, Ali SR, Ibrahim N, et al. Could vitamins help in the fight against COVID-19? Nutrients. 2020;12(9):2550.
   PubMed Web of Science ®Google Scholar
• Shadyro OI, Glushonok GK, Glushonok TG, et al. Quinones as free-radical fragmentation inhibitors in biologically important molecules. Free Rad. Res. 2002;36(8):859–867.
   PubMed Web of Science ®Google Scholar
• Shadyro OI, Kisel RM, Vysotskii VV, et al. Effects of vitamins, coenzymes and amino acids on reactions of homolytic cleavage of the O-glycoside bond in carbohydrates. Bioorg Med Chem Lett. 2006;16(18):4763–4766.
   PubMed Web of Science ®Google Scholar
• Shadyro OI, Sosnovskaya АА, Edimecheva IP, et al. Effects of various vitamins and coenzymes Q on reactions involving alpha-hydroxyl-containing radicals. Free Radic Res. 2005;39(7):713–718.,
   PubMed Web of Science ®Google Scholar
• Samovich SN, Sverdlov RL, Voitekhovich SV, et al. Effects of quinones and azoles on radiation-induced processes involving hydroxyl-containing carbon-centered radicals. Rad Phys Chem. 2018;144:308–316.
   Web of Science ®Google Scholar
• Ahmad A, Rehman MU, Ahmad P, et al. Covid-19 and thymoquinone: connecting the dots. Phytother Res. 2020;34(11):2786–2789.
   PubMed Web of Science ®Google Scholar
• Gökalp F. The chemical activity of Juglone in different phases as a protective agent. J Fluorine Chem. 2021; 242:109701.
   Web of Science ®Google Scholar
• Dabaghian F, Khanavi M, Zarshenas MM. Bioactive compounds with possible inhibitory activity of Angiotensin-Converting Enzyme-II; a gate to manage and prevent COVID-19. Med Hypotheses. 2020;143:109841
   PubMed Web of Science ®Google Scholar
• Ghaffari Agdam MH, Sharifi S, Soleimani F, et al. Anti-SARS-CoV and anti-cancer effects of emodin. Adv Herbal Med. 2019;5:42–53. http://herbmed.skums.ac.ir/article_45838_76c72ba3e986e2a3b5959dbe8577c534.pdf
   Google Scholar
• Brinkevich SD, Shadyro OI. Effects of coenzyme Q0, ascorbic acid, and its glycoside on the radiation-induced dephosphorylation of organic phosphates in aqueous solutions. High Energy Chem. 2009;43(6):435–439.
   Web of Science ®Google Scholar
• Brinkevich SD, Shadyro OI. The effects of ascorbic acid on homolytic processes involving alpha-hydroxyl-containing carbon-centered radicals . Bioorg Med Chem Lett. 2008;18(24):6448–6450.
   PubMed Web of Science ®Google Scholar
• Hryntsevich IB, Shadyro OI. Reactions of α-hydroxyethyl radicals with flavonoids of various structures. Bioorg Med Chem Lett. 2005;15(19):4252–4255.
   PubMed Web of Science ®Google Scholar
• Brinkevich SD, Ostrovskaya NI, Parkhach ME, et al. Effects of curcumin and related compounds on processes involving α-hydroxyethyl radicals. Free Rad Res. 2012;46(3):295–302.,
   PubMed Web of Science ®Google Scholar
• Samovich SN, Brinkevich SD, Shadyro OI. Interaction of aromatic alcohols, aldehydes and acids with α-hydroxyl-containing carbon-centered radicals: a steady state radiolysis study. Rad Phys Chem. 2013;82:35–43.
   Web of Science ®Google Scholar
• Zahedipour F, Hosseini SA, Sathyapalan T, et al. Potential effects of curcumin in the treatment of COVID-19 infection. Phytother Res. 2020;34(11):2911–2920.
   PubMed Web of Science ®Google Scholar
• Babaei F, Nassiri-Asl M, Hosseinzadeh H. Curcumin (a constituent of turmeric): New treatment option against COVID-19. Food Sci Nutr. 2020;8(10):5215–5213.
   PubMed Web of Science ®Google Scholar
• Kim WY, Jo EJ, Eom JS, et al. Combined vitamin C, hydrocortisone, and thiamine therapy for patients with severe pneumonia who were admitted to the intensive care unit: propensity score-based analysis of a before-after cohort study. J Crit Care. 2018;47:211–218.,
   PubMed Web of Science ®Google Scholar
• Cheng RZ. Can early and high intravenous dose of vitamin C prevent and treat coronavirus disease 2019 (COVID-19)? Med Drug Discov. 2020;5:100028.
   PubMedGoogle Scholar
• Biancatelli RMLC, Berrill M, Catravas JD, et al. Quercetin and vitamin C: an experimental, synergistic therapy for the prevention and treatment of SARS-CoV-2 related disease (COVID-19). Front Immunol. 2020;11:1451.
   PubMed Web of Science ®Google Scholar
• Bellavite P, Donzelli A. Hesperidin and SARS-CoV-2: new light on the healthy function of citrus fruits. Antioxidants. 2020;9(8):742.
   Web of Science ®Google Scholar
• Lammi C, Arnoldi A. Food‐derived antioxidants and COVID‐19. J Food Biochem. 2021;45(1):e13557.
   PubMed Web of Science ®Google Scholar
• Roberts N, Brown RE, Buja LM, et al. Molecular mechanisms of curcumin in COVID-19 treatment and prevention: a global health perspective. Med Res Arch. 2020;8(10).
   Google Scholar
• Agrawal PK, Agrawal C, Blunden G. Quercetin: antiviral significance and possible COVID-19 integrative considerations. Nat Prod Commun. 2020;15(12):1934578X2097629.
   Web of Science ®Google Scholar
• Derosa G, Maffioli P, D'Angelo A, et al. A role for quercetin in coronavirus disease 2019 (COVID‐19). Phytother Res. 2020;35:1230–1236.
   PubMed Web of Science ®Google Scholar